Therapeutic targeting of ATR in alveolar rhabdomyosarcoma
2022 · Nature Communications · 28 citations
https://doi.org/10.1038/s41467-022-32023-7
J
Jennifer von Stebut
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
54
Papers
151
Citations
5
h-index
4
i10-index
Jennifer von Stebut is an academic researcher from Humboldt-Universität zu Berlin. The author has contributed to research in topics: Neuroblastoma Research and Treatments & Cancer therapeutics and mechanisms & Advanced Breast Cancer Therapies. The author has an h-index of 5, co-authored 46 publications.
ORCID: 0000-0001-9811-445XPapers by this author
worksSupplementary Figure 7 from Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models
2024 · 0 citations
https://doi.org/10.1158/1535-7163.25523202.v1
Data from Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models
2024 · 0 citations
https://doi.org/10.1158/1535-7163.c.7160202.v1
Supplementary Figure 8 from Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models
2024 · 0 citations
https://doi.org/10.1158/1535-7163.25523199.v1
Supplementary Figure 9 from Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models
2024 · 0 citations
https://doi.org/10.1158/1535-7163.25523193.v1
Supplementary Figure 10 from Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models
2024 · 0 citations
https://doi.org/10.1158/1535-7163.25523229
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat